These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10314291)

  • 1. Developing a successful strategy for controlling inappropriate antibiotic use and cost.
    Mu-Chow KJ; Rich DS
    Top Hosp Pharm Manage; 1988 Aug; 8(2):1-21. PubMed ID: 10314291
    [No Abstract]   [Full Text] [Related]  

  • 2. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic review performed by a pharmacy and therapeutics subcommittee.
    Klapp DL; Ramphal R
    QRB Qual Rev Bull; 1982 Jan; 8(1):15-9. PubMed ID: 6803205
    [No Abstract]   [Full Text] [Related]  

  • 5. Concurrent antibiotic-use review in a small hospital.
    Kerns MP; Meyer GE
    Am J Hosp Pharm; 1986 Jun; 43(6):1476-8. PubMed ID: 3728483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital restriction policy for newly marketed antimicrobial agents.
    Jeffrey LP; McCloskey WW; Rich DS; Mahoney CD
    Am J Hosp Pharm; 1986 Sep; 43(9):2230-2. PubMed ID: 3766580
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling the costs of antibiotic resistance.
    North D
    Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the hospital pharmacy. Interview by Nancy M. Agresta.
    Lantos RL
    Hosp Formul; 1979 Sep; 14(9):839-43. PubMed ID: 10243910
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic review: the experience of one pharmacy and therapeutics committee.
    Kiepert DR
    QRB Qual Rev Bull; 1979 Jan; 5(1):24-7. PubMed ID: 121376
    [No Abstract]   [Full Text] [Related]  

  • 13. Procedure for evaluating nonformulary drug orders.
    Jay GT; Quercia RA; Gousse G; Chow MS; Quintiliani R
    Am J Hosp Pharm; 1993 Dec; 50(12):2554-6. PubMed ID: 8122692
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
    Carlson JA
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of the use of antimicrobial agents in a regional hospital and its effect on prescription behavior].
    Sturm AW
    Ned Tijdschr Geneeskd; 1985 Oct; 129(42):2023-6. PubMed ID: 4069269
    [No Abstract]   [Full Text] [Related]  

  • 16. A pharmacy-based antibiotic UR program.
    Cohen SS
    QRB Qual Rev Bull; 1984 Jan; 10(1):22-5. PubMed ID: 6422381
    [No Abstract]   [Full Text] [Related]  

  • 17. P&T Committee antibiotic cost considerations.
    Rinehart JR
    Hosp Formul; 1986 Aug; 21(8):857-9, 862-4. PubMed ID: 10277580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture and antibiotic monitoring service in a community hospital.
    Von Seggern RL
    Am J Hosp Pharm; 1987 Jun; 44(6):1358-62. PubMed ID: 3303924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for deleting popular drugs from a hospital formulary.
    Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
    Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.